The ruling allows the whistleblowers to further pursue their claims against the pharmacies, alleging they violated the False Claims Act when they charged Medicare and Medicaid far more than they charged customers for drugs.

Two whistleblowers brought suit on behalf of the federal government, alleging SuperValu's pharmacies failed to submit "usual and customary" prices, which impacts the discount that the pharmacy will receive when reimbursed.